Business Context and Reporting Period
This Form 8-K, filed on March 3, 2005, by The Clorox Company, addresses the reclassification of financial statements for the three-year period ended June 30, 2004. The filing reflects the treatment of the "Transferred Businesses" (insecticide and Soft Scrub cleanser businesses) and a 20% interest in the Henkel Iberica, S.A. joint venture as discontinued operations. This reclassification follows a November 2004 transaction where Clorox exchanged these assets and approximately $2.1 billion in cash for 61.4 million shares of its own common stock owned by a subsidiary of HENKEL KGaA.
Key Financial Metrics
The filing does not provide specific revenue, profit, or cash flow figures for the current period within the text of the 8-K itself, as the detailed reclassified financial statements are contained in Exhibit 99.1. However, the following specific financial items are noted:
- Transaction Cash Consideration: Approximately $2.1 billion in cash was exchanged as part of the transaction with HENKEL KGaA.
- Joint Venture Liability: An increase of $133 million in net terminal obligation liability was recognized regarding the joint venture with Procter & Gamble (Glad business).
- Discontinued Operations: Financial results for the Transferred Businesses, including gains on the exchange, are now reported in discontinued operations for the periods ended December 31, 2004, and 2003, and retrospectively for the three years ended June 30, 2004.
Material Changes Versus Prior Period
The primary material change is the retrospective reclassification of the Transferred Businesses and the Henkel Iberica interest as discontinued operations in the financial statements for fiscal years 2002, 2003, and 2004. This alters the presentation of historical revenue and profit metrics for those periods. Additionally, the filing notes a change in the Procter & Gamble joint venture where P&G exercised an option to increase its interest in the Glad business from 10% to 20%, resulting in the aforementioned $133 million liability increase.
Guidance, Outlook, and Risks
The filing explicitly states that it does not address developments in the Procter & Gamble joint venture beyond the liability recognition or the company's segment realignment in January 2005, as these are covered in the Form 10-Q for the period ended December 31, 2004. The reclassified financial statements in Exhibit 99.1 have not been updated to reflect developments after June 30, 2004. No forward-looking guidance or specific risk factors are detailed in the text of this 8-K beyond the context of the reclassification.
Investor Verification Checklist
- Review Exhibit 99.1 for the full reclassified financial statements and Management's Discussion and Analysis for fiscal years 2002-2004.
- Verify the impact of the $133 million increase in net terminal obligation liability on the company's balance sheet.
- Consult the Form 10-Q for the period ended December 31, 2004, for details on the segment realignment and further developments in the Procter & Gamble joint venture.
- Confirm that the $2.1 billion cash outflow and the share repurchase (61.4 million shares) are accurately reflected in the cash flow and equity sections of the reclassified statements.